标题
Omics Profiling in Precision Oncology
作者
关键词
-
出版物
MOLECULAR & CELLULAR PROTEOMICS
Volume 15, Issue 8, Pages 2525-2536
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2016-04-21
DOI
10.1074/mcp.o116.059253
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare
- (2016) Weijie Zhao et al. LUNG CANCER
- The Precision Medicine Initiative
- (2015) Euan A. Ashley JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Single molecule and single cell epigenomics
- (2015) Byung-Ryool Hyun et al. METHODS
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Personalized genomic analyses for cancer mutation discovery and interpretation
- (2015) Siân Jones et al. Science Translational Medicine
- ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability
- (2015) Matthias Scheffler et al. Oncotarget
- Knowledge Discovery and interactive Data Mining in Bioinformatics - State-of-the-Art, future challenges and research directions
- (2014) Andreas Holzinger et al. BMC BIOINFORMATICS
- Proteogenomic characterization of human colon and rectal cancer
- (2014) Bing Zhang et al. NATURE
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Serine, but Not Glycine, Supports One-Carbon Metabolism and Proliferation of Cancer Cells
- (2014) Christiaan F. Labuschagne et al. Cell Reports
- Targeting MET Amplification as a New Oncogenic Driver
- (2014) Hisato Kawakami et al. Cancers
- A Novel Grading System for Clear Cell Renal Cell Carcinoma Incorporating Tumor Necrosis
- (2013) Brett Delahunt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
- (2013) Daniel F Hayes BMC Medicine
- RETfusion gene: Translation to personalized lung cancer therapy
- (2013) Takashi Kohno et al. CANCER SCIENCE
- Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance
- (2013) D Gonzalez de Castro et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A new genome-driven integrated classification of breast cancer and its implications
- (2013) Sarah-Jane Dawson et al. EMBO JOURNAL
- Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets
- (2013) Alessandro Gronchi et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
- (2013) Juan Sandoval et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Criteria for the use of omics-based predictors in clinical trials
- (2013) Lisa M. McShane et al. NATURE
- Emerging landscape of oncogenic signatures across human cancers
- (2013) Giovanni Ciriello et al. NATURE GENETICS
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prioritization of Cancer Marker Candidates Based on the Immunohistochemistry Staining Images Deposited in the Human Protein Atlas
- (2013) Su-Chien Chiang et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- When Tissue Antigens and Antibodies Get Along
- (2013) J. A. Ramos-Vara et al. VETERINARY PATHOLOGY
- A Functional Copy-Number Variation in MAPKAPK2 Predicts Risk and Prognosis of Lung Cancer
- (2012) Bin Liu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review
- (2012) Agnieszka Smolinska et al. ANALYTICA CHIMICA ACTA
- Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non–Small Cell Lung Cancer: The 2004 World Health Organization Classification and Therapeutically Relevant Subsets
- (2012) Juneko E. Grilley-Olson et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes
- (2012) Rui Chen et al. CELL
- Transcriptional data: a new gateway to drug repositioning?
- (2012) Francesco Iorio et al. DRUG DISCOVERY TODAY
- Translating cancer 'omics' to improved outcomes
- (2012) E. A. Vucic et al. GENOME RESEARCH
- Genetic Changes in Squamous Cell Lung Cancer: A Review
- (2012) Rebecca S. Heist et al. Journal of Thoracic Oncology
- Chipping away at the lung cancer genome
- (2012) William Pao et al. NATURE MEDICINE
- Vemurafenib: the first drug approved for BRAF-mutant cancer
- (2012) Gideon Bollag et al. NATURE REVIEWS DRUG DISCOVERY
- HMDB 3.0—The Human Metabolome Database in 2013
- (2012) David S. Wishart et al. NUCLEIC ACIDS RESEARCH
- Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges
- (2012) Purvesh Khatri et al. PLoS Computational Biology
- Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples
- (2011) Serban Nacu et al. BMC Medical Genomics
- Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
- (2011) Mary L. Disis CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC–MS and multivariate statistical analysis
- (2011) Wuwen Lv et al. CLINICAL BIOCHEMISTRY
- Genome-scale analysis of aberrant DNA methylation in colorectal cancer
- (2011) T. Hinoue et al. GENOME RESEARCH
- Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) Shows Differential Antitumor Effects in Non-small Cell Lung Cancer According to MET Alterations
- (2011) Junko Tanizaki et al. Journal of Thoracic Oncology
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- Bioinformatics tools for cancer metabolomics
- (2011) Grigoriy Blekherman et al. Metabolomics
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Predictive biomarkers: a paradigm shift towards personalized cancer medicine
- (2011) Nicholas B. La Thangue et al. Nature Reviews Clinical Oncology
- Personalized cancer medicine and the future of pathology
- (2011) H. Moch et al. VIRCHOWS ARCHIV
- International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data
- (2011) J. Zhang et al. Database-The Journal of Biological Databases and Curation
- Identification of fusion genes in breast cancer by paired-end RNA-sequencing
- (2011) Henrik Edgren et al. GENOME BIOLOGY
- Integrative analysis of the melanoma transcriptome
- (2010) M. F. Berger et al. GENOME RESEARCH
- Towards proteome standards: The use of absolute quantitation in high-throughput biomarker discovery
- (2010) Tzu-Chiao Chao et al. Journal of Proteomics
- The Current State of Chromatin Immunoprecipitation
- (2010) Philippe Collas MOLECULAR BIOTECHNOLOGY
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- Visualization of omics data for systems biology
- (2010) Nils Gehlenborg et al. NATURE METHODS
- Gene-expression-based prognostic assays for breast cancer
- (2010) Chungyeul Kim et al. Nature Reviews Clinical Oncology
- RNA sequencing: advances, challenges and opportunities
- (2010) Fatih Ozsolak et al. NATURE REVIEWS GENETICS
- Bayesian approach to transforming public gene expression repositories into disease diagnosis databases
- (2010) H. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Integrative -omics Approach to Identify Functional Sub-Networks in Human Colorectal Cancer
- (2010) Rod K. Nibbe et al. PLoS Computational Biology
- Global Levels of Histone Modifications Predict Prognosis in Different Cancers
- (2009) David B. Seligson et al. AMERICAN JOURNAL OF PATHOLOGY
- Potential of Human Saliva for Nuclear Magnetic Resonance-Based Metabolomics and for Health-Related Biomarker Identification
- (2009) Hanne Christine Bertram et al. ANALYTICAL CHEMISTRY
- ChIP–seq: advantages and challenges of a maturing technology
- (2009) Peter J. Park NATURE REVIEWS GENETICS
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Epigenetic Changes in Cancer
- (2008) Christine A. Iacobuzio-Donahue Annual Review of Pathology-Mechanisms of Disease
- RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays
- (2008) J. C. Marioni et al. GENOME RESEARCH
- Metabolic Profiling of Human Colorectal Cancer Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS)
- (2008) Eric Chun Yong Chan et al. JOURNAL OF PROTEOME RESEARCH
- Translating insights from the cancer genome into clinical practice
- (2008) Lynda Chin et al. NATURE
- Reverse-phase protein lysate microarrays for cell signaling analysis
- (2008) Brett Spurrier et al. Nature Protocols
- RNA-Seq: a revolutionary tool for transcriptomics
- (2008) Zhong Wang et al. NATURE REVIEWS GENETICS
- Predictive data mining in clinical medicine: Current issues and guidelines
- (2007) R BELLAZZI et al. INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More